A case of COVID-19 in a patient with pemphigus on azathioprine: Successful management with methylprednisolone

Authors

  • Abdullah Demirbaş Department of Dermatology, Kocaeli University, Faculty of Medicine, Kocaeli, Türkiye
  • Ömer Faruk Elmas Department of Dermatology, Medicana International Hospital, İstanbul, Türkiye
  • Mustafa Atasoy Department of Dermatology, Memorial Ataşehir Hospital, İstanbul, Türkiye
  • Ümit Türsen Department of Dermatology, Mersin University, Faculty of Medicine, Mersin, Türkiye
  • Asuman Kilitci Department of Pathology, Düzce University, Faculty of Medicine, Düzce, Türkiye
  • Torello Lotti Department of Dermatology, Guglielmo Marconi University, Rome, Italy

DOI:

https://doi.org/10.53545/jbm.2024.41

Keywords:

Pemphigus, COVID-19, azathioprine, methylprednisolone

Abstract

COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus that first appeared in Wuhan, China. It is not just a respiratory disease but a multisystem disease. Risk factors for mortality and morbidity include advanced age, male gender, hypertension and immunosuppressive conditions. We present the case of COVID-19 that developed in a 31-year-old female patient who received azathioprine therapy with a diagnosis of pemphigus.

Downloads

Published

2024-11-26

How to Cite

Demirbaş, A., Elmas, Ömer F., Atasoy, M., Türsen, Ümit, Kilitci, A., & Lotti, T. (2024). A case of COVID-19 in a patient with pemphigus on azathioprine: Successful management with methylprednisolone. Journal of Bionic Memory , 4(3), 64–67. https://doi.org/10.53545/jbm.2024.41

Issue

Vol. 4 No. 3 (2024): Journal of Bionic Memory

Section

Articles

License

Copyright (c) 2024 Abdullah Demirbaş, Ömer Faruk Elmas, Mustafa Atasoy, Ümit Türsen, Asuman Kilitci, Torello Lotti

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.